Sign In
Buy AVDL
$21.64
+0 (+0%)
At Close: May 08, 2026
Hedge Funds Have Never Been More Bullish On Avadel Pharmaceuticals plc (AVDL)
01:13am, Sunday, 28'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Avadel Pharmaceuticals PLC (NASDAQ:AVDL) Expected to Post Earnings of -$0.14 Per Share
06:14am, Wednesday, 24'th Jun 2020
Wall Street brokerages expect Avadel Pharmaceuticals PLC (NASDAQ:AVDL) to announce ($0.14) earnings per share for the current quarter, Zacks reports. Three analysts have made estimates for Avadel Phar
Supernus Pharmaceuticals (SUPN) Got Some Good News - Markets
09:34am, Tuesday, 16'th Jun 2020
In a report released today, David Amsellem from Piper Sandler upgraded Supernus Pharmaceuticals (SUPN – Research Report) to Buy, with
Avadel Pharmaceuticals to Present at BIO Digital
12:00pm, Monday, 08'th Jun 2020
DUBLIN, Ireland, June 08, 2020 -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium.
Jazz Pharmaceuticals: Pandemic Leaves The Leading Drug In A Catch 22 (NASDAQ:JAZZ)
04:56pm, Monday, 01'st Jun 2020
As the pandemic fears squeeze the new patient enrollments for Xyrem, JAZZ has downgraded the revenue guidance. While the economic downturn stifles the revenue g
How Avadel (AVDL) Stock Stands Out in a Strong Industry
01:20pm, Monday, 01'st Jun 2020
Avadel (AVDL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Avadel Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
12:00pm, Monday, 01'st Jun 2020
DUBLIN, Ireland, June 01, 2020 -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium.
2 Top Healthcare Stocks to Buy Right Now
09:54am, Thursday, 28'th May 2020
One is a blue chip, the other a small-cap, but both are innovators with significant growth opportunities.
Coronavirus Impact on Healthcare Acquired Infection Market
04:45pm, Tuesday, 26'th May 2020
May 26, 2020 (Heraldkeepers) --
New York, May 26, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports...
Avadel Pharmaceuticals plc (AVDL) Q1 2020 Earnings Call Transcript
06:30pm, Monday, 11'th May 2020
It is now my pleasure to introduce your host Tom McHugh, Chief Financial Officer. As a reminder before we begin the following presentation includes several matters that constitute forward-looking sta
Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q1 2020 Results - Earnings Call Transcript
04:44pm, Monday, 11'th May 2020
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2020 Earnings Conference Call May 11, 2020 08:30 AM ET Company Participants Thomas McHugh - Chief Financial Officer
Avadel (AVDL) Beats on Earnings & Revenue Estimates in Q1
02:17pm, Monday, 11'th May 2020
Avadel's (AVDL) first quarter 2020 earnings and revenues surpass expectations.
Strongbridge Biopharma: Attractive Valuation With Catalysts Approaching
01:44pm, Monday, 11'th May 2020
SBBP shares continue to be significantly discounted relative to the opportunity for Recorlev as a treatment for Cushing's Syndrome. Peak revenue estimates for R
Avadel Pharmaceuticals Reports First Quarter 2020 Financial Results
11:00am, Monday, 11'th May 2020
Reported positive topline data from the pivotal Phase 3 REST-ON studyStrengthened balance sheet with $190 million in gross proceeds from a private placement in February 2020 and.
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
